Ironwood Pharmaceuticals Inc (IRWD)

Ironwood Pharmaceuticals Inc (IRWD) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $620M; returns 1 day -3.1%, 1 week -1.1%, 1 year +112.3%.

Ironwood Pharmaceuticals is a commercial-stage biotechnology company focused on developing and commercializing therapies for gastrointestinal (GI) and rare diseases. The company's revenue is overwhelmingly generated from its flagship product, LINZESS (linaclotide), for which it has a 50/50 profit-sharing collaboration with AbbVie in the United States.

Groups IRWD belongs to

• Gastroenterology
• Commercial Stage Biotech
• Biotechnology
• Pharmaceuticals
• Healthcare
• Digestive Health
• Rare Diseases
• Life Sciences
• Biopharmaceutical

IRWD financial model: income statement, cash flow and balance sheet